Home-based cervical cancer screening for HIV-positive women in Nigeria
Community, Home-based Education, Screening Services (CHESS) Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria
This study is testing a new program to help HIV-positive women in Nigeria get screened for cervical cancer and see how well it works.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 25 Years to 50 Years |
| Sex | Female |
| Sponsor | Emory University Academic / other |
| Locations | 3 sites (Abuja and 2 other locations) |
| Trial ID | NCT06751030 on ClinicalTrials.gov |
What this trial studies
This observational study aims to adapt and implement a program that promotes HPV and cervical cancer screening for HIV-positive women in Nigeria. The study will tailor the existing MoMent program through stakeholder input to enhance its effectiveness in this population. It will evaluate the program's reach, effectiveness, adoption, and fidelity, involving a sample of 1,500 women living with HIV. Additionally, a post-implementation evaluation will identify barriers and facilitators to the program's sustainability and scalability.
Who should consider this trial
Good fit: Ideal candidates for this study are women living with HIV who are between the ages of 25 and 50 and can perform vaginal self-collection.
Not a fit: Patients who are male, under 25 or over 50, pregnant, have had a hysterectomy, or cannot provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve access to cervical cancer screening and follow-up treatment for HIV-positive women in Nigeria.
How similar studies have performed: Other studies have shown success with similar community-based approaches to cancer screening, indicating potential for this program's effectiveness.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Patients must be able to perform vaginal self-collection as well as give informed consent Exclusion Criteria: * Male gender * Age \<25 or \>50 * Unknown or negative HIV status * Pregnancy * Hysterectomy * Inability to give informed consent Inability/refusal to perform vaginal self-collection
Where this trial is running
Abuja and 2 other locations
- APIN Health Initiatives — Abuja, Nigeria (Recruiting)
- University of Ibadan — Ibadan, Nigeria (Recruiting)
- Nigeria Institute of Medical Research (NIMR — Lagos, Nigeria (Recruiting)
Study contacts
- Principal investigator: Lisa Flowers, MD, MPH — Emory University
- Study coordinator: Lisa Flowers, MD, MPH
- Email: Lflowe2@emory.edu
- Phone: 404-712-3522
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.